Browse the evidence

The activation of GIPR by LAGIPRA or THDBH120 alleviated inflammation.

GIPR activation may be beneficial for reducing inflammation in obesity-related conditions.

Tirzepatide is associated with lower mortality compared to both semaglutide and SGLT2 inhibitors.

Tirzepatide may offer a survival advantage for patients with type 2 diabetes.

GLP-1 receptor agonists (GLP-1 RAs) have demonstrated anti-inflammatory, antioxidative, and immunomodulatory properties.

GLP-1 RAs may be beneficial in managing inflammation and immune responses.

The use of dual and triple agonists was associated with a higher risk of any adverse events (RR 1.13; 95% CI: 1.08-1.19).

Clinicians should be aware of the potential for increased adverse events when prescribing incretin polyagonists.

KN069 was well tolerated, with predominantly mild-to-moderate gastrointestinal adverse events.

KN069 may be a safe option for weight management in this population.

Obesity and obstructive sleep apnea (OSA) contribute to cardiovascular disease through interconnected mechanisms.

Practitioners should consider the combined effects of obesity and OSA when addressing cardiovascular health.

GLP-1 RA use was associated with significantly lower occupational therapy utilization (RR = 0.686, p < 0.011).

GLP-1 RAs may reduce the need for occupational therapy in rotator cuff repair patients.

Muscle volume decreased in the injured muscle compared to the contralateral healthy muscle during the intervention by −9.4% (−13.5% to −5.3%), p < 0.0001, and this decrease persisted at 12 months.

Rehabilitation programs should consider the persistent loss of muscle volume after strain injuries.

There was a persistent increase in aponeurosis volume associated with the injured muscle at 3 months and 12 months, but it was unaffected by protein supplementation.

Increased aponeurosis volume may indicate structural changes in muscle healing, regardless of protein intake.

Neither collagen nor whey protein ingestion further increased muscle connective protein synthesis rates during the early stages of post-exercise recovery.

Collagen protein may not be effective for enhancing muscle connective tissue recovery post-exercise.

The concept of diabesity is based on the twin epidemics of obesity and diabetes.

Healthcare providers should understand the link between obesity and diabetes in managing diabesity.

Lipotoxicity and inflammation cause insulin resistance in the liver and muscle.

Understanding these mechanisms can aid in developing treatment strategies for insulin resistance.

Age-related insulin resistance arises from interconnected mechanisms, including inflammaging, cellular senescence, and mitochondrial dysfunction.

Understanding these interconnected mechanisms can help in developing targeted interventions for older adults.

Muscle metabolic quality, rather than adiposity alone, emerges as a key determinant of insulin sensitivity in older adults.

Emphasizing muscle quality in interventions may improve insulin sensitivity in older patients.

Innovative obesity therapies could transform long-term outcomes of preeclampsia.

Practitioners should stay informed about new obesity therapies that may improve long-term health outcomes for women with preeclampsia.

Modern research has identified various factors that modulate insulin resistance, indicating the need for targeted therapies.

Identifying modulating factors can help in developing personalized treatment strategies for insulin resistance.

Stage 2 obesity requires excess waist circumference or waist-to-height ratio, along with symptoms or comorbid conditions.

Practitioners should assess waist measurements and related symptoms for obesity classification.

Most upper airway anatomy was significantly associated with BMI among patients with OSA.

Practitioners should consider the impact of BMI on upper airway anatomy when assessing OSA.

All pharyngeal soft tissues were larger with greater BMI, including the volumes of the tongue, soft palate, and lateral walls.

Increased soft tissue volume with higher BMI should be considered in OSA management.

Understanding novel mutations in POMC and MC4R/MC3R may help identify strategies for the treatment and diagnosis of obesity, particularly childhood obesity.

This knowledge can guide interventions for childhood obesity.

Antidiabetic medications impact skeletal muscle lipid metabolism.

Practitioners should consider the effects of antidiabetic medications on lipid metabolism when treating patients.

Interventions like ASK-1 knockout, nitrate, and melatonin have increased thermogenesis and improved metabolic outcomes.

Consider these interventions to enhance thermogenesis in metabolic health strategies.

Metabolische unerwünschte Arzneimittelwirkungen (mUAW) von Psychopharmaka umfassen Gewichtszunahme, gestörte Glukosetoleranz, Diabetes mellitus und Dyslipidämie.

Healthcare providers should monitor metabolic parameters in patients on psychotropic medications.

Lower body mass index is a significant independent factor for paraspinal muscle atrophy in preoperative lumbar spinal stenosis and lumbar disk herniation patients.

Practitioners should consider body mass index when assessing risk for muscle atrophy in these patients.